Mr. Martin’s base salary in FY 2011 constituted $1.1 million of the $3.7 million. Non-equity incentive plan compensation and other bonuses — which included meeting targets of adjusted EBITDA — totaled $2.59 million. Mr. Martin also received $14,208 in “other compensation,” which included a matching contribution made under Vanguard’s 401(k) plan and insurance premiums.
Kent Wallace, Vanguard president and COO, made $2.13 million in total compensation in FY 2011, a 50 percent increase from FY 2010. The large increase, similar to Mr. Martin, was due to bonuses received from meeting financial goals. Mr. Wallace’s base salary was $685,000.
Vanguard CFO Phillip Roe earned $1.67 million last fiscal year, which included a $525,000 base salary and more than $1.1 million in bonuses and non-equity incentive plan compensation. In FY 2010, Mr. Roe recorded $965,165 in total compensation.
Bradley Perkins, MD, chief transformation officer, made more than $3.46 million. Roughly $1.9 million of that total reflected stock awards.
More Articles on Hospital Executive Compensation:
IASIS CEO Carl Whitmer’s Compensation Hits $5.58M in 2011
Average Hospital General Counsel Salaries Rise to 57% of CEO Salaries
Cape Fear Valley in North Carolina Awards CEO Salary Raise, Bonus
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
